Kelly Epplen, PharmD, Named ASHP Fellow
In recognition of excellence achieved in pharmacy practice, Kelly Epplen, PharmD, an assistant professor in the James L. Winkle College of Pharmacy, has been named a fellow by the American Society of Health-System Pharmacists (ASHP).
ASHP is a national professional organization whose more than 40,000 members include pharmacists, pharmacy technicians and student pharmacists who provide patient care services in hospitals, health systems and ambulatory clinics. Awarding fellowship in the ASHP is one means by which the organization fosters and rewards demonstrated excellence in hospital and health-system pharmacy.
To earn fellowship status, Epplen, who is also an ambulatory clinical pharmacist with St. Elizabeth Healthcare Family Care Center in Northern Kentucky, had to: successfully demonstrate sustained commitment or contributions to practice for at least 10 years; prove contribution to the total body of knowledge in the field; demonstrate active involvement and leadership in ASHP and other professional organizations; and have been actively involved and committed to educating practitioners and others.
Since earning her PharmD at UC (97), Epplen says she has been passionate regarding the education of patients about their disease and associated medication regimens and as an educator her philosophy has always been "to teach students to place patient care at the forefront of everythingtruly making their practice patient-centered. In addition to clinical practice, she has been precepting students from the Winkle College of Pharmacy since 1998.
Epplen will be honored Tuesday, June 3, 2014, during the ASHP Summer Meetings and Exhibition in Las Vegas.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.